JMDC (4483) Fundamentals 2026 — P/E 31.8x, Revenue Analysis | SniperIQ
JMDC (4483) is a JP-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ¥215.3B, trading at ¥3290.00 on the JPX. This SniperIQ fundamentals page covers JMDC's valuation (P/E 31.8x, P/B 2.6x), profitability (net margin 13.4%), revenue (¥50.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is JMDC's market cap?
JMDC (4483) has a market capitalization of approximately ¥215.3B, trading at ¥3290.00 on the JPX. Market cap moves with the live share price.
What is JMDC's P/E ratio?
JMDC's trailing twelve-month P/E ratio is 31.8x, with a price-to-book (P/B) of 2.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is JMDC?
JMDC runs a net profit margin of 13.4%, a gross margin of 54.9%, and an operating margin of 19.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does JMDC generate?
JMDC reported revenue of ¥50.5B for fiscal year 2025, with net income of ¥6.8B and earnings per share (EPS) of 103.43. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does JMDC pay a dividend?
JMDC offers a trailing dividend yield of about 0.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is JMDC financially healthy?
JMDC carries a debt-to-equity ratio of 0.62x and a current ratio of 2.27x, with a market beta of 0.82. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is JMDC a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For JMDC (4483) the key facts are: market cap ¥215.3B, P/E 31.8x, revenue ¥50.5B, 52-week range 2369-4950. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track JMDC's full fundamentals live
Get JMDC's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.